|
2025 Conference Publication Real-world Experience With Inhaled Liposomal Amikacin Suspension for Treatment of Nontuberculous Mycobacterial Pulmonary DiseaseTwining, M., Kang, S., Riddles, T., Evans, I., Burke, A.J. and Thomson, R. (2025). Real-world Experience With Inhaled Liposomal Amikacin Suspension for Treatment of Nontuberculous Mycobacterial Pulmonary Disease. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a5444 |
|
2024 Conference Publication Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case studyMattison, Graeme, Keating, Rebecca, McWhinney, Brett, Connors, Shannon, Swenson, Rebecca, Evans, Ieuan, Burke, Andrew and Burr, Lucy (2024). Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2–4 August 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication High prevalence of rare CFTR mutation phenotypes in people with cystic fibrosis in Queensland, AustraliaEvans, Ieuan and Reid, David (2024). High prevalence of rare CFTR mutation phenotypes in people with cystic fibrosis in Queensland, Australia. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Conference Publication Disproportionate rates of liver impairment in Australian cystic fibrosis patients initiated on elexacaftor/tezacaftor/ivacaftor (ETI)Johnson, Ellie, Evans, Ieuan and Reid, David (2024). Disproportionate rates of liver impairment in Australian cystic fibrosis patients initiated on elexacaftor/tezacaftor/ivacaftor (ETI). 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Conference Publication Sodium intake of adults with cystic fibrosis living in north Queensland post elexacaftor-tezacaftor-ivacaftorHerd, Karen, Matson, Angela, Loel, Felicity, Moore, Vanessa and Evans, Ieuan (2024). Sodium intake of adults with cystic fibrosis living in north Queensland post elexacaftor-tezacaftor-ivacaftor. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Conference Publication Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in QueenslandWood, Michelle, Smith, Iain, Hiscock, Keirran, Smith, Daniel, Keating, Rebecca, Burr, Lucy, Tay, George, Zimmerman, Maureen, Feather, Iain, Cobb, Robyn, Moore, Vanessa, Evans, Ieuan, Reid, David, Masel, Philip, Mackintosh, John and Henderson, Daniel (2024). Multi-centre experience of elexacaftor-tezacaftor-ivacaftor use in adult cystic fibrosis transplant recipients in Queensland. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2-4 August 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Evaluating the outcomes of CFTR modulator therapy on the rates of non-tuberculous mycobacteria isolated from patients in a cystic fibrosis (CF) cohortEvans, Ieuan Edward Shepherd, Smith, Daniel and Reid, David William (2024). Evaluating the outcomes of CFTR modulator therapy on the rates of non-tuberculous mycobacteria isolated from patients in a cystic fibrosis (CF) cohort. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2–4 August 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication A prospective study analysing the CFTR modulator impact on innate immunity in cystic fibrosis airwayFernando, Amali, Jurak, Lisa, Essilfie, Ama-Tawiah, Wood, Michelle, Smith, Iain, Hiscock, Keirran, Cobb, Robyn, Moore, Vanessa, Henderson, Daniel, Evans, Ieuan, Smith, Daniel and Reid, David (2024). A prospective study analysing the CFTR modulator impact on innate immunity in cystic fibrosis airway. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
